OLFM3 activators are a class of compounds specifically designed to modulate the activity of Olfactomedin 3 (OLFM3), a protein encoded by the OLFM3 gene which belongs to the olfactomedin domain-containing protein family. OLFM3 is known to be involved in various cellular processes, and its precise biological functions are an active area of research. Activators of OLFM3 would interact with the protein to enhance its natural activity within the cell. This could involve increasing protein stability, promoting its interaction with other cellular components, or facilitating its role in signaling pathways. The molecular mechanisms through which OLFM3 activators exert their effects would depend on the protein's structure, including its active and binding sites, as well as the specific activator molecules and how they interact with OLFM3.
To develop OLFM3 activators, researchers must first gain a comprehensive understanding of the protein's structure and function. This involves using techniques such as X-ray crystallography, cryo-electron microscopy, or NMR spectroscopy, which can reveal the three-dimensional arrangement of atoms within the OLFM3 protein and highlight potential sites for activator binding. With structural data in hand, a combination of computational chemistry and experimental assays is used to identify molecules that can bind to and enhance the activity of OLFM3. Computational approaches, like molecular docking and simulation, allow for the virtual screening of large libraries of compounds to predict their interactions with OLFM3. Promising candidates are then synthesized and subjected to further biochemical assays to assess their impact on OLFM3 function. These assays may include measuring changes in protein-protein interactions, protein stability, or monitoring the downstream effects on signaling pathways in which OLFM3 is implicated. Compounds that successfully demonstrate activity-enhancing effects undergo optimization to refine their potency, selectivity, and overall molecular properties such as solubility and metabolic stability.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Stimulates adenylate cyclase, leading to increased cAMP levels. Higher cAMP can activate various pathways that might influence OLFM3 expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
A metabolite of Vitamin A, retinoic acid acts on retinoic acid receptors, affecting gene expression. It can potentially modulate OLFM3 if it is within its target genes. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
A glucocorticoid that can regulate gene expression by acting on glucocorticoid receptors. If OLFM3 is a target, it may be modulated. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
A known PKC activator. If OLFM3 is involved in PKC-mediated pathways, PMA can potentially influence its activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
A calcium ionophore that raises intracellular calcium levels. If OLFM3 is calcium-responsive, ionomycin can modulate its function. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
A histone deacetylase (HDAC) inhibitor that can affect gene expression. If OLFM3 expression is influenced by histone acetylation, sodium butyrate can modulate it. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
A β-adrenergic receptor agonist. It can increase cAMP levels and activate related pathways, potentially influencing OLFM3 if it's responsive to such pathways. | ||||||
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $96.00 $166.00 $459.00 $1615.00 | 12 | |
A strong inducer of inflammation. If OLFM3 plays a role in inflammatory pathways, LPS can influence its activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
mTOR pathways play a role in many cellular functions. If OLFM3 is involved in mTOR-responsive pathways, its function might be modulated. | ||||||
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $57.00 $184.00 $867.00 | 10 | |
If OLFM3 is part of the Wnt signaling pathway, chemicals activating this pathway might influence OLFM3's function. | ||||||